ArticleMedicina clinica2022

Commercialized kits to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in health care workers.

Mónica Martínez-Gallo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.